Michael Otto on using probiotics to reduce Staphylococcus aureus
from The Lancet Microbe in conversation with Hosted by The Lancet Microbe
Rebecca Barksby of The Lancet Microbe talks to Dr Michael Otto and his and his collaborators’ placebo-controlled phase 2 trial that used the probiotic Bacillus subtilis to reduce Staphylococcus aureus in adults who were colonised by the bacteria in the Songkhla region of Thailand. Read the full article: Probiotic for pathogen-specific Staphylococcus aureus decolonisation in Thailand Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Embed this episode
No transcript yet.